Thalidomide for graft-versus-host disease - PubMed (original) (raw)
Thalidomide for graft-versus-host disease
G B Vogelsang et al. Lancet. 1988.
Free article
No abstract available
Similar articles
- Thalidomide treatment for chronic graft-versus-host disease.
Heney D, Norfolk DR, Wheeldon J, Bailey CC, Lewis IJ, Barnard DL. Heney D, et al. Br J Haematol. 1991 May;78(1):23-7. doi: 10.1111/j.1365-2141.1991.tb04377.x. Br J Haematol. 1991. PMID: 2043478 - Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease.
Flowers ME, Martin PJ. Flowers ME, et al. Leuk Lymphoma. 2003 Jul;44(7):1141-6. doi: 10.1080/1042819031000079096. Leuk Lymphoma. 2003. PMID: 12916865 Review. - High-performance liquid chromatographic assay of plasma thalidomide: stabilization of specimens and determination of a tentative therapeutic range for chronic graft-versus-host disease.
Boughton BJ, Sheehan TM, Wood J, O'Brien D, Butler M, Simpson A, Hale KA. Boughton BJ, et al. Ann Clin Biochem. 1995 Jan;32 ( Pt 1):79-83. doi: 10.1177/000456329503200108. Ann Clin Biochem. 1995. PMID: 7762955 - The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information.
Wood PM, Proctor SJ. Wood PM, et al. Leuk Res. 1990;14(5):395-9. doi: 10.1016/0145-2126(90)90024-4. Leuk Res. 1990. PMID: 2189044 Free PMC article. Review. - Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model.
Vogelsang GB, Wells MC, Santos GW, Chen TL, Hess AD. Vogelsang GB, et al. Transplant Proc. 1988 Apr;20(2 Suppl 2):226-8. Transplant Proc. 1988. PMID: 3284069 No abstract available.
Cited by
- The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview.
Boieri M, Shah P, Dressel R, Inngjerdingen M. Boieri M, et al. Front Immunol. 2016 Aug 30;7:333. doi: 10.3389/fimmu.2016.00333. eCollection 2016. Front Immunol. 2016. PMID: 27625651 Free PMC article. Review. - Multiple myeloma.
Rajkumar SV. Rajkumar SV. Curr Probl Cancer. 2009 Jan-Feb;33(1):7-64. doi: 10.1016/j.currproblcancer.2009.01.001. Curr Probl Cancer. 2009. PMID: 19254626 Free PMC article. Review. No abstract available. - Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid.
Cao Z, Joseph WR, Browne WL, Mountjoy KG, Palmer BD, Baguley BC, Ching LM. Cao Z, et al. Br J Cancer. 1999 May;80(5-6):716-23. doi: 10.1038/sj.bjc.6690415. Br J Cancer. 1999. PMID: 10360649 Free PMC article. - Thalidomide--the way forward.
Gardner-Medwin JM, Powell RJ. Gardner-Medwin JM, et al. Postgrad Med J. 1994 Dec;70(830):860-2. doi: 10.1136/pgmj.70.830.860. Postgrad Med J. 1994. PMID: 7870630 Free PMC article. No abstract available. - FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.
Tzakis AG, Abu-Elmagd K, Fung JJ, Bloom EJ, Nour B, Greif F, Starzl TE. Tzakis AG, et al. Transplant Proc. 1991 Dec;23(6):3225-7. Transplant Proc. 1991. PMID: 1721416 Free PMC article. No abstract available.